Patient Assistance & Copay Programs for Gamifant Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Full Answer
What is Gamifant used for?
How much does a free drug card save?
About this website
What is Gamifant used for?
GAMIFANT is indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.
How is Gamifant administered?
Gamifant is administered as an intravenous infusion over 1 hour twice a week (every 3 to 4 days) until HSCT is performed or unacceptable toxicity.
Who makes Gamifant?
Gamifant (emapalumab) was developed by Swiss specialist pharma company Novimmune and gained FDA approval in November 2018. The treatment is for children and adults with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance to conventional HLH therapy.
What is HLH disease?
Hemophagocytic lymphohistiocytosis (HLH) is an aggressive and life-threatening syndrome of excessive immune activation. It most frequently affects infants from birth to 18 months of age, but the disease is also observed in children and adults of all ages.
Is Gamifant approved in Europe?
After re-examining its initial opinion, the European Medicines Agency has confirmed its recommendation to refuse marketing authorisation for the medicine Gamifant. The medicine was intended for the treatment of primary haemophagocytic lymphohistiocytosis (HLH) in children under 18 years of age.
What is primary HLH?
Primary (or familial) HLH is an inherited version of the disease. This means it often runs in families and typically presents during infancy or early childhood. It is estimated that primary HLH affects about 1 in every 50,000 births. Secondary (or acquired) HLH generally is diagnosed in older children and adults.
When was Gamifant FDA approved?
Development timeline for GamifantDateArticleNov 20, 2018Approval FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic LymphohistiocytosisSep 4, 2019
What can trigger HLH?
Acquired HLH in adults can be caused by:Viral infections, most often Epstein-Barr virus.Other infections from bacteria or fungi.Some types of cancer, such as T-cell lymphoma.Autoimmune diseases.Medicines that suppress the immune system.
How long can adults live with HLH?
Adult HLH is a rare and almost universally fatal disease entity without treatment with published median survival of 1.8–2.2 months.
What causes death in HLH?
Therefore, the cause of death was deemed to be HLH triggered by SFTSV infection. HLH is a life-threatening disease that is caused by excessive activation of the immune system and is associated with many underlying conditions (8,9).
What is the survival rate for HLH?
Familial HLH is fatal without treatment, with median survival of about two to six months. Chemotherapy and/or immunotherapy temporarily control the disease, but symptoms inevitably return.
How does HLH start?
HLH occurs when histiocytes and lymphocytes become overactive and attack the body rather than just bacteria and viruses. Histiocytes are phagocytes—cells that engulf and destroy pathogens. Lymphocytes are a form of white blood cell with several subtypes.
Does Covid cause HLH?
COVID-19-associated haemophagocytic lymphohistiocytosis (HLH) can present as a postacute COVID-19 syndrome, even after a pauci-symptomatic initial infection. The development of HLH after a SARS-CoV-2 infection is rare and represents an aberrant virus–host interaction.
How do you detect HLH?
HLH can be diagnosed only with the proper tests. Blood tests include blood cell counts, liver function, infection studies, and markers of immune system activation such as ferritin and soluble IL-2 receptor levels. A bone marrow aspirate and biopsy may be performed to look for microscopic evidence of hemophagocytosis.
What is Gamifant used for?
Gamifant (emapalumab) is a member of the selective immunosuppressants drug class and is commonly used for Hemophagocytic Lymphohistiocytosis.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
How to contact Gamifant?
Download the Start Form now or contact Gamifant Patient Services at 833-597-6530.
How often is Gamifant given?
Gamifant is given as an intravenous infusion twice per week until the patient no longer requires therapy for the treatment of HLH or until hematopoietic stem cell transplantation (HSCT) is performed. 1. Access & Support.
What is gamifant works?
HOw Gamifant WOrks. Gamifant binds to soluble and receptor-bound forms of IFNγ. Binding to IFNγ neutralizes its activity, blocking its intracellular signaling to inhibit macrophage activation and the downstream release of proinflammatory cytokines. 1,2,6,7. Read more.
Can Gamifant be titrated downward?
Depending on patient response, Gamifant can be incrementally titrated upward or downward. Similarly, the concomitant dose of dexamethasone may be tapered from the original starting dose according to the judgment of the treating physician. 1
What is Gamifant used for?
Gamifant® (emapalumab-lzsg) is an interferon gamma (IFNγ)-blocking antibody indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent, or progressive disease or intolerance with conventional HLH therapy.
What should be evaluated before initiating Gamifant?
Before initiating Gamifant, patients should be evaluated for infection, including latent tuberculosis (TB). Prophylaxis for TB should be administered to patients who are at risk for TB or known to have positive purified protein derivative (PPD) test result or positive IFNγ release assay.
What are the reactions of Gamifant?
Infusion-related reactions, including drug eruption, pyrexia, rash, erythema, and hyperhidrosis, were reported with Gamifant treatment in 27% of patients. In one-third of these patients, the infusion-related reaction occurred during the first infusion.
What is Gamifant used for?
Gamifant (emapalumab) is a member of the selective immunosuppressants drug class and is commonly used for Hemophagocytic Lymphohistiocytosis.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
